TITLE

Long-term Culture of Human SSEA-4 Positive Spermatogonial Stem Cells (SSCs)

AUTHOR(S)
Kokkinaki, Maria; Djourabtchi, Ardalan; Golestaneh, Nady
PUB. DATE
July 2012
SOURCE
Journal of Stem Cell Research & Therapy;Special2012, Vol. 2 Issue S, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Recently we and two other groups have shown that human spermatogonial stem cells (SSCs) have the potential to become pluripotent in vitro in defined culture conditions and to differentiate into cells of the three embryonic germ layers. This discovery could open new avenues for autologous cell-based therapy in degenerative diseases, bypassing the ethical and immunological problems related to the human embryonic stem cells. In addition, human SSCs could be used to treat infertility in cancer survival children. However, in order to reprogram SSCs into pluripotency, or to preserve them for repopulation of infertile testes, the first and limiting step is to have access to a highly purified human SSC population that could be multiplied and efficiently cultured in vitro maintaining their molecular and cellular characteristics. Although various studies have attempted to identify molecular markers of human SSCs, to date there is still limited information related to the specific markers that could be used for their isolation and optimized purification that allows long-term in vitro culture of isolated human SSCs. Here using SSEA-4 as an optimal marker for isolation of a subpopulation of SSCs, we show that SSEA-4 positive cells express the highest level of SSC genes compared to other subpopulations isolated with different markers, and can be maintained in culture for over 14 passages which we were unable to obtain with other SSCs markers including GPR125 and ITGA6. In addition, we have established a new technology for cell sorting and long-term culture of human SSC-SSEA-4 positive cells that maximizes the purity and viability of the sorted cells. Our findings are crucial and could be used for the most efficient isolation, purification and long-term culture of SSCs for clinical applications in regenerative medicine, or for preparation of human SSCs for autologous treatment of infertility in cancer survival children.
ACCESSION #
86429441

 

Related Articles

  • Generating cells of the gastrointestinal system: current approaches and applications for the differentiation of human pluripotent stem cells. Wang, Allen; Sander, Maike // Journal of Molecular Medicine;Jul2012, Vol. 90 Issue 7, p763 

    Human pluripotent stem cells (hPSCs), including human embryonic stem cells and induced pluripotent stem cells, are defined by their abilities to self-renew and to differentiate into any cell type of the human body. Due to these unique properties, hPSCs represent a potentially unlimited source of...

  • Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells. Andrews, Peter W; Cavanagro, Joy; Deans, Robert; Feigel, Ellen; Horowitz, Ed; Keating, Armand; Rao, Mahendra; Turner, Marc; Wilmut, Ian; Yamanaka, Shinya // Nature Biotechnology;Aug2014, Vol. 32 Issue 8, p724 

    The article reports on standardization of clinical grade therapies from pluripotent stem cells as of August 2014. The topics discussed include in vitro conversion of embryonic stem cells (ESCs), pluripotent stem cells (iPSCs) ability to make any differentiated cell type, and compliance of...

  • INDUCED PLURIPOTENT STEM CELLS: HOW THEY WILL CHANGE THE PRACTICE OF CARDIOVASCULAR MEDICINE. Wing Tak Wong; Sayed, Nazish; Cooke, John P. // Methodist DeBakey Cardiovascular Journal;Oct-Dec2013, Vol. 9 Issue 4, p206 

    Induced pluripotent stem cells (iPSCs) can be generated from adult somatic tissues by the forced expression of a few defined transcription factors, including Oct4, Sox2, Klf4, and c-Myc. iPSC technology holds tremendous promises for therapeutic cardiovascular regeneration because of the cells'...

  • Human stem cell research and regenerative medicine—present and future. Volarevic, Vladislav; Ljujic, Biljana; Stojkovic, Petra; Lukic, Aleksandra; Arsenijevic, Nebojsa; Stojkovic, Miodrag // British Medical Bulletin;Sep2011, Vol. 99 Issue 1, p155 

    Introduction Stem cells are cells with the ability to grow and differentiate into more than 200 cell types. Sources of data We review here the characteristics and potential of human embryonic stem cells (hESCs), induced pluripotent stem cells (iPSCs) and adult stem cells (ASCs). Areas of...

  • Cell therapy for type 1 diabetes. Muir, K.R.; Lima, M.J.; Docherty, H.M.; Docherty, K. // QJM: An International Journal of Medicine;Apr2014, Vol. 107 Issue 4, p253 

    Cell therapy in the form of human islet transplantation has been a successful form of treatment for patients with type 1 diabetes for over 10 years, but is significantly limited by lack of suitable donor material. A replenishable supply of insulin-producing cells has the potential to address...

  • Induction of multipotency in umbilical cord-derived mesenchymal stem cells cultivated under suspension conditions. Amiri, Fatemeh; Halabian, Raheleh; Salimian, Morteza; Shokrgozar, Mohammad; Soleimani, Masoud; Jahanian-Najafabadi, Ali; Roudkenar, Mehryar // Cell Stress & Chaperones;Sep2014, Vol. 19 Issue 5, p657 

    Due to the limitations in the clinical application of embryonic stem cells (ESC) and induced pluripotent stem cells, mesenchymal stem cells (MSCs) are now much more interesting for cell-based therapy. Although MSCs have several advantages, they are not capable of differentiating to all three...

  • Keeping an eye on stem cells for studying disease modelling and cell-based therapy. Crombie, Duncan // Australasian Biotechnology;Mar2013, Vol. 23 Issue 1, p19 

    The article discusses the use of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) in treating eye-related diseases. Topics featured in the discussion include regenerative medicine, cell differentiation, and stem cell-based therapy. It mentions the Centre for Eye Research...

  • Well-defined differentiation of hesc-derived hemangioblasts by embryoid body formation without enzymatic treatment. Gil, Chang-Hyun; Lee, Ji-heon; Seo, Joseph; Park, Soon-Jung; Park, Zewon; Kim, Jumi; Jung, A-Ra; Lee, Won-Young; Kim, Jong-Soo; Moon, Sung-Hwan; Lee, Hoon-Taek; Chung, Hyung-Min // Biotechnology Letters;Jun2015, Vol. 37 Issue 6, p1315 

    Human hemangioblasts exist only during the early embryonic developmental stage thereby limiting the adult cellular source from which to obtain such cells for study. To overcome this, hemangioblast studies have focused on utilizing human embryonic stem cell (hESC) derivatives but current methods...

  • Stem cell biology-from basic research to regenerative medicine. Besser, Daniel // Journal of Molecular Medicine;Jul2012, Vol. 90 Issue 7, p731 

    An introduction is presented in which the editor discusses various reports within the issue on topics including pluripotent stem cells, cellular therapy and embryonic stem cells.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics